
Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Canonical is a San Francisco-based early-stage venture capital firm founded in 2022, focusing on the infrastructure necessary for a post-AGI world. The firm is led by experienced operators in technology, including Anand Iyer, who serves as Managing Partner. Canonical aims to assist technical founders in developing transformative systems and infrastructure that will support future AI technologies.
The firm has an initial fund size of $20 million, backed by notable limited partners such as Marc Andreessen, Chris Dixon, and Lux Capital. Canonical's investment strategy emphasizes foundational systems in AI, blockchain, and robotics, targeting pre-product and seed-stage companies. The firm has evolved its thesis from a pure crypto focus to a broader scope that includes AI and robotics.
Canonical's commitment to long-term alignment and patient capital allows them to provide extensive support to their portfolio companies. Their office is located in San Francisco, CA, and they have established a reputation for backing technical founders who are building the essential infrastructure for a decentralized AI future.
Canonical invests in foundational systems that will underpin future AI technologies, with a specific focus on sectors such as AI infrastructure, blockchain, and robotics. Their investment strategy is built around six core principles: open infrastructure, blockchain as a foundation, pre-product focus, technical depth, long-term alignment, and network effects.
The firm emphasizes transparency and permissionless innovation in AI systems, leveraging blockchain technology to ensure equitable value distribution. Canonical seeks to support pre-product founders who are developing open AI networks, providing them with the technical expertise necessary to build complex infrastructure. Their long-term vision is to align with founders who are committed to transformative technology, ensuring that they have the resources and support needed to succeed.
Canonical's approach includes providing portfolio companies access to a network of builders, researchers, and investors in AI and blockchain, which enhances their ability to scale and innovate. This focus on foundational systems positions Canonical as a key player in the evolving landscape of AI and blockchain technologies.
Canonical partners with teams developing the infrastructure for a decentralized AI future. While specific portfolio companies were not detailed, the firm is known to support ventures that align with their investment thesis. Notable mentions include:
Canonical's portfolio emphasizes 'n-of-1' technical founding teams that are building the 'picks-and-shovels' of the post-AGI future. This strategic focus on foundational infrastructure positions their portfolio companies to play critical roles in the development of future AI technologies.
Anand Iyer - Managing Partner and Founder. Anand has a background as the former CEO and co-founder of Trusted and has held venture roles at Pear VC and Lightspeed Venture Partners. He has experience at Microsoft and holds a degree in Computer Engineering from Purdue University.
Anthony Avedissian - Partner. Anthony is a co-founder of Seed Club Ventures, which has a $25 million fund. He has made over 70 pre-seed and seed investments and previously worked as an investor at Amber Capital. He also founded Anteo Health.
To pitch Canonical, founders should visit their website at canonical.cc. They prefer direct applications through their online platform. In the pitch deck, founders should include a clear description of their technology, the problem it solves, and the team's technical qualifications.
Canonical values transparency and clarity in pitches, so founders should be prepared to discuss their long-term vision and how they plan to achieve it. Response times may vary, but founders can expect to hear back after their submission is reviewed.
In 2022, Canonical launched its initial fund with a size of $20 million, focusing on early-stage investments in AI, blockchain, and robotics. The fund has garnered attention from notable LPs, including Marc Andreessen and Chris Dixon.
Canonical has been featured in various media outlets, including PRNewswire, TechCrunch, and Blockworks, highlighting their investment strategy and focus on foundational infrastructure for a post-AGI world.
What are Canonical's investment criteria?
Canonical invests in pre-product and seed-stage companies focused on foundational systems in AI, blockchain, and robotics. They look for technical founders with deep expertise and innovative ideas that align with their investment thesis.
How can founders apply or pitch to Canonical?
Founders can pitch to Canonical by visiting their website at canonical.cc. They encourage direct applications through their online platform.
What makes Canonical different from other venture firms?
Canonical differentiates itself by focusing on foundational infrastructure for a post-AGI world, emphasizing long-term alignment and patient capital. Their network of builders, researchers, and investors in AI and blockchain provides unique support to portfolio companies.
What is Canonical's geographic scope?
Canonical primarily invests in North America, targeting early-stage companies that are developing innovative technologies in AI and blockchain.
What is Canonical's approach to post-investment involvement?
Canonical provides extensive support to portfolio companies, leveraging their technical expertise and network to assist founders in building complex infrastructure. They focus on long-term relationships and patient capital to help companies grow.
What is the typical fund size and check size for Canonical?
Canonical's initial fund size is $20 million, and they typically invest in pre-seed and seed-stage companies, although specific check sizes are not disclosed.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.